February 1st 2023
By Brielle Benyon
The first patient was dosed with lerapolturev in a phase 1/2 clinical trial evaluating the drug in patients with bladder cancer and other solid tumors.
February 1st 2023
By Colleen Moretti
A new standard of care for advanced pancreatic neuroendocrine tumors demonstrates improvements in survival and tumor shrinkage.
February 1st 2023
By Julie S. Brokaw
I’m coming up on my 10-year cancer anniversary, and it feels bittersweet.
February 1st 2023
By Darlene Dobkowski, MA
Older patients with advanced cancer who were taking eight or more medications before starting treatment were more likely to discontinue treatment and/or experience a side effect from drug interactions.
February 1st 2023
By Darlene Dobkowski, MA
The TRANSCNED CLL 004 trial met its primary endpoint of complete responses with the CAR-T cell therapy Breyanzi in patients with relapsed or refractory CLL or SLL.
February 1, 2023 6:00 PM
By Julie S. Brokaw
January 31, 2023 6:00 PM
By Chelsey Gomez
January 30, 2023 6:00 PM
By Mary Sansone
January 27, 2023 6:00 PM
By Bonnie Annis
January 4, 2023 4:00 PM
December 30, 2022 8:00 PM
December 30, 2022 2:00 PM
December 29, 2022 8:00 PM
January 28, 2023 7:00 PM
By Wendy Reichental
January 26, 2023 2:00 PM
By Stephanie Landon
January 25, 2023 4:00 PM
By Shoba Rao
January 23, 2023 8:00 PM
By John Smelcer, PhD, CAGS
Direct-to-Bladder Immunotherapy Drug to Be Studied in Bladder Cancer
Chemo Combo Adds More to the Treatment Toolbox for Advanced Pancreatic NETs
Anniversary Time: A Look Back of What I’ve Learned 10 Years After Cancer
Taking 8-Plus Medications Before Cancer Treatment May Affect Effectiveness in Older Patients